Target Price | $43.17 |
Price | $27.19 |
Potential |
58.76%
register free of charge
|
Number of Estimates | 6 |
6 Analysts have issued a price target ARCA biopharma, Inc. 2025 .
The average ARCA biopharma, Inc. target price is $43.17.
This is
58.76%
register free of charge
$49.00
80.21%
register free of charge
$40.00
47.11%
register free of charge
|
|
A rating was issued by 7 analysts: 7 Analysts recommend ARCA biopharma, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the ARCA biopharma, Inc. stock has an average upside potential 2025 of
58.76%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -4.44 | -1.74 |
543.48% | 60.81% | |
P/E | negative |
3 Analysts have issued a ARCA biopharma, Inc. forecast for earnings per share. The average ARCA biopharma, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
ARCA biopharma, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.